Do analysts rate OGI or ACB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer CGC or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts prefer CRON or OGI?

Cronos Group presently has a consensus price target of $2.30, indicating a potential downside of 18.73%. Given Cronos Group's higher probable upside, equities research analysts plainly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend OGI or SNDL?

SNDL has a consensus target price of $5.00, suggesting a potential upside of 306.50%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings & valuation, OGI or SNDL?

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Organigram Global $274.19M 0.48 -$17.70M -$0.13 N/A SNDL $677.32M 0.47 -$11.29M -$0.06 N/A

Is OGI or SNDL more profitable?

SNDL has a net margin of -2.36% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -2.01% beat Organigram Global's return on equity. Company Net Margins Return on Equity Return on Assets Organigram Global -9.22% -13.41% -9.09% SNDL -2.36% -2.01% -1.67%

Do analysts recommend TLRY or OGI?

Tilray Brands presently has a consensus price target of $11.00, indicating a potential upside of 142.29%. Given Tilray Brands' stronger consensus rating and higher possible upside, research analysts clearly believe Tilray Brands is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.50 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Organigram Global (OGI) Competitors

$0.94 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$0.93 -0.01 (-1.31%)

As of 07/31/2026 07:45 PM Eastern

Compare

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

Should you buy Organigram Global stock or one of its competitors? MarketBeat compares Organigram Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Organigram Global include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), and Tilray Brands (TLRY).

How does Organigram Global compare to Aurora Cannabis?

Organigram Global (NASDAQ:OGI) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Organigram Global has a net margin of -9.22% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
Aurora Cannabis	-33.57%	0.10%	0.07%

In the previous week, Aurora Cannabis had 3 more articles in the media than Organigram Global. MarketBeat recorded 3 mentions for Aurora Cannabis and 0 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.89 beat Aurora Cannabis' score of 0.25 indicating that Organigram Global is being referred to more favorably in the media.

Company	Overall Sentiment
Organigram Global	Positive
Aurora Cannabis	Neutral

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Organigram Global has higher revenue and earnings than Aurora Cannabis. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$274.19M	0.48	-$17.70M	-$0.13	N/A
Aurora Cannabis	$247.82M	0.70	-$88.13M	-$1.56	N/A

Organigram Global has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

Summary

Organigram Global beats Aurora Cannabis on 9 of the 15 factors compared between the two stocks.

How does Organigram Global compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

In the previous week, Canopy Growth had 3 more articles in the media than Organigram Global. MarketBeat recorded 3 mentions for Canopy Growth and 0 mentions for Organigram Global. Canopy Growth's average media sentiment score of 1.00 beat Organigram Global's score of 0.89 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Canopy Growth	Positive
Organigram Global	Positive

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by company insiders. Comparatively, 0.1% of Organigram Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Organigram Global has lower revenue, but higher earnings than Canopy Growth. Organigram Global is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$284.60M	1.45	-$190.29M	-$0.59	N/A
Organigram Global	$274.19M	0.48	-$17.70M	-$0.13	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Canopy Growth has a beta of 0.79, meaning that its stock price is 21% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market.

Organigram Global has a net margin of -9.22% compared to Canopy Growth's net margin of -75.27%. Organigram Global's return on equity of -13.41% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Organigram Global	-9.22%	-13.41%	-9.09%

Summary

Organigram Global beats Canopy Growth on 8 of the 14 factors compared between the two stocks.

How does Organigram Global compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

Cronos Group presently has a consensus price target of $2.30, indicating a potential downside of 18.73%. Given Cronos Group's higher probable upside, equities research analysts plainly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cronos Group has higher earnings, but lower revenue than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$159.54M	6.62	-$9.45M	$0.01	283.00
Organigram Global	$274.19M	0.48	-$17.70M	-$0.13	N/A

Cronos Group has a net margin of -1.14% compared to Organigram Global's net margin of -9.22%. Cronos Group's return on equity of -1.26% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Organigram Global	-9.22%	-13.41%	-9.09%

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 3 mentions for Cronos Group and 0 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.89 beat Cronos Group's score of 0.25 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Neutral
Organigram Global	Positive

Cronos Group has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market.

Summary

Cronos Group beats Organigram Global on 10 of the 15 factors compared between the two stocks.

How does Organigram Global compare to SNDL?

Organigram Global (NASDAQ:OGI) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

SNDL has a consensus target price of $5.00, suggesting a potential upside of 306.50%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Organigram Global has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market. Comparatively, SNDL has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$274.19M	0.48	-$17.70M	-$0.13	N/A
SNDL	$677.32M	0.47	-$11.29M	-$0.06	N/A

SNDL has a net margin of -2.36% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -2.01% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
SNDL	-2.36%	-2.01%	-1.67%

In the previous week, SNDL had 23 more articles in the media than Organigram Global. MarketBeat recorded 23 mentions for SNDL and 0 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.89 beat SNDL's score of 0.02 indicating that Organigram Global is being referred to more favorably in the media.

Company	Overall Sentiment
Organigram Global	Positive
SNDL	Neutral

34.6% of Organigram Global shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Organigram Global and SNDL tied by winning 8 of the 16 factors compared between the two stocks.

How does Organigram Global compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

In the previous week, Tilray Brands had 33 more articles in the media than Organigram Global. MarketBeat recorded 33 mentions for Tilray Brands and 0 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.89 beat Tilray Brands' score of 0.48 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Tilray Brands	Neutral
Organigram Global	Positive

Organigram Global has a net margin of -9.22% compared to Tilray Brands' net margin of -13.11%. Tilray Brands' return on equity of -7.76% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-13.11%	-7.76%	-5.59%
Organigram Global	-9.22%	-13.41%	-9.09%

Tilray Brands presently has a consensus price target of $11.00, indicating a potential upside of 142.29%. Given Tilray Brands' stronger consensus rating and higher possible upside, research analysts clearly believe Tilray Brands is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.50
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.8% of Tilray Brands shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Tilray Brands has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, Organigram Global has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

Organigram Global has lower revenue, but higher earnings than Tilray Brands. Organigram Global is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$915.45M	0.58	-$121.40M	-$1.08	N/A
Organigram Global	$274.19M	0.48	-$17.70M	-$0.13	N/A

Summary

Tilray Brands beats Organigram Global on 12 of the 17 factors compared between the two stocks.

Get Organigram Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OGI vs. The Competition

Export

Metric	Organigram Global	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$132.42M	$5.58B	$6.86B	$12.42B
Dividend Yield	N/A	1.79%	2.59%	10.03%
P/E Ratio	-7.23	23.12	282.30	24.66
Price / Sales	0.48	56.86	561.34	76.65
Price / Cash	N/A	32.53	28.60	46.71
Price / Book	0.51	6.29	10.98	6.07
Net Income	-$17.70M	$151.15M	$3.49B	$347.99M
7 Day Performance	-0.01%	1.02%	-0.60%	-0.44%
1 Month Performance	-8.81%	-3.43%	-5.20%	-4.81%
1 Year Performance	-29.38%	2.35%	62.01%	18.61%

Organigram Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OGI Organigram Global	0.8814 of 5 stars	$0.94 flat	N/A	-29.4%	$132.42M	$274.19M	N/A	1,139	Gap Up
ACB Aurora Cannabis	0.7628 of 5 stars	$2.72 -0.7%	N/A	-37.7%	$166.85M	$247.82M	N/A	1,028	Upcoming Earnings
CGC Canopy Growth	1.2236 of 5 stars	$0.89 -3.3%	N/A	-12.6%	$400.97M	$284.60M	N/A	1,128	Positive News Upcoming Earnings
CRON Cronos Group	0.8386 of 5 stars	$2.85 -0.3%	$2.30 -19.3%	+45.1%	$1.06B	$159.54M	285.29	450	Upcoming Earnings Gap Up
SNDL SNDL	2.7763 of 5 stars	$1.22 -9.6%	$5.00 +309.8%	-25.5%	$314.02M	$937.39M	N/A	2,751	Earnings Report Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OGI) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Summary

How does Organigram Global compare to Canopy Growth?

Summary

How does Organigram Global compare to Cronos Group?

Summary

How does Organigram Global compare to SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Do analysts rate OGI or ACB?

Is OGI or ACB more profitable?

Does the media refer more to OGI or ACB?

Do institutionals and insiders have more ownership in OGI or ACB?

Which has preferable valuation and earnings, OGI or ACB?

Which has more volatility and risk, OGI or ACB?

Summary

How does Organigram Global compare to Canopy Growth?

Does the media prefer CGC or OGI?

Do insiders and institutionals have more ownership in CGC or OGI?

Which has better valuation and earnings, CGC or OGI?

Do analysts prefer CGC or OGI?

Which has more risk and volatility, CGC or OGI?

Is CGC or OGI more profitable?

Summary

How does Organigram Global compare to Cronos Group?

Do analysts prefer CRON or OGI?

Do institutionals & insiders have more ownership in CRON or OGI?

Which has preferable earnings & valuation, CRON or OGI?

Is CRON or OGI more profitable?

Does the media favor CRON or OGI?

Which has more risk & volatility, CRON or OGI?

Summary

How does Organigram Global compare to SNDL?

Do analysts recommend OGI or SNDL?

Which has more risk and volatility, OGI or SNDL?

Which has higher earnings & valuation, OGI or SNDL?

Is OGI or SNDL more profitable?

Does the media prefer OGI or SNDL?

Do insiders & institutionals hold more shares of OGI or SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Does the media prefer TLRY or OGI?

Is TLRY or OGI more profitable?

Do analysts recommend TLRY or OGI?

Do institutionals & insiders have more ownership in TLRY or OGI?

Which has more risk & volatility, TLRY or OGI?

Which has stronger earnings & valuation, TLRY or OGI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools